Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CEAM1 | P13688 | Cell adhesion molecule CEACAM1 (Biliary glycoprotein 1) (BGP-1) (Carcinoembryonic antigen-related cell adhesion molecule 1) (CEA cell adhesion molecule 1) (CD antigen CD66a) | CD markersPlasma proteinsPredicted intracellular proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| CLCN2 | P51788 | Chloride channel protein 2 (ClC-2) | Disease related genesFDA approved drug targetsHuman disease related genes | 10 | Epilepsy | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| CLIP2 | Q9UDT6 | CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein) | Disease related genesHuman disease related genesPlasma proteins | Williams-Beuren syndrome | Fusion and delivery mediation | 1 | 0.53 | |||
| CLTR1 | Q9Y271 | Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Allergic/hypersensitivity disorderAsthmaMigraine | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.53 | ||
| CN37 | P09543 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37) | Disease related genesEnzymesHuman disease related genes | Leukodystrophy | Immune mediation | 1 | 0.53 | |||
| CNPY3 | Q9BT09 | Protein canopy homolog 3 (CTG repeat protein 4a) (Expanded repeat-domain protein CAG/CTG 5) (Protein associated with TLR4) (Trinucleotide repeat-containing gene 5 protein) | Disease related genesHuman disease related genesPredicted intracellular proteins | Epilepsy | Immune mediation | 1 | 0.53 | |||
| CNTFR | P26992 | Ciliary neurotrophic factor receptor subunit alpha (CNTF receptor subunit alpha) (CNTFR-alpha) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | GlaucomaInherited retinal dystrophyMacular degeneration | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | |||
| COHA1 | Q9UMD9 | Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)] | Cancer-related genesDisease related genesHuman disease related genes | 1 | Epidermolysis bullosa | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 1 | 0.53 | ||
| COQ7 | Q99807 | NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial (EC 1.14.13.253) (3-demethoxyubiquinone 3-hydroxylase (NADH)) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7) | Disease related genesEnzymesHuman disease related genes | Primary mitochondrial disease | Immune mediationMetabolism mediation | 1 | 0.53 | |||
| CRFR2 | Q13324 | Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2) | 7 | Anxiety disorderBinge eating disorderHeart failure | Clinical-translation mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.53 |